The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 345:1495-1497 November 15, 2001 Number 20
NextNext

Therapy for Acute Hepatitis C

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
- PDF
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Jaeckel, E.
-PubMed Citation
Infection with the hepatitis C virus (HCV) is now the most frequent cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma in the United States and most Western nations.1,2,3 Population-based surveys show that 1 to 2 percent of adults in the United States are chronically infected with HCV.2 Although hepatitis C has been described as an epidemic and a national emergency, the epidemic reflects the identification of chronic cases rather than a large outbreak of new cases.

Acute hepatitis C is no longer very common in the United States. The incidence has decreased from a peak level of 250,000 to 500,000 . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.